SGK1-IN-4

CAS No. 1628048-93-0

SGK1-IN-4( —— )

Catalog No. M29000 CAS No. 1628048-93-0

SGK1-IN-4 is a selective inhibitor of SGK1 and can be used in studies about osteoarthritis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 318 Get Quote
5MG 264 Get Quote
10MG 376 Get Quote
25MG 613 Get Quote
50MG 807 Get Quote
100MG 1079 Get Quote
200MG 1451 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SGK1-IN-4
  • Note
    Research use only, not for human use.
  • Brief Description
    SGK1-IN-4 is a selective inhibitor of SGK1 and can be used in studies about osteoarthritis.
  • Description
    SGK1-IN-4 is a selective inhibitor of SGK1 and can be used in studies about osteoarthritis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1628048-93-0
  • Formula Weight
    517.96
  • Molecular Formula
    C23H21ClFN5O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (482.66 mM)
  • SMILES
    O(C1=C2C(=NC(=N1)C3=CC=C(NS(=O)(=O)C4=C(F)C=CC(Cl)=C4)C=C3)NN=C2)[C@@H]5CC[C@@H](O)CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Glenzocimab

    Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.

  • Somatostatin-14 (3-1...

    Somatostatin-14 (3-14) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.

  • Bruceine A

    Bruceine A(NSC310616; Dihydrobrusatol) is a natural quassinoid compound extracted from the dried fruits of Brucea javanica (L.); are potential candidates for the treatment of canine babesiosis.